InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Peters Richard, Président et CEO. Insider active across 2 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 8 filings have been published. Total volume traded: €29k. The latest transaction was disclosed on 3 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€11,34010,206 shares@ €1.111110.1% of flow
Common Stock
SEC:0000899243-22-021283:0·
€17,98710,715 shares@ €1.678716.0% of flow
Common Stock
SEC:0000899243-22-012782:0·
070,000 shares0
Common Stock
SEC:0000899243-21-046760·
070,000 shares0
Common Stock
SEC:0000899243-21-046760:0·
€41,6504,441 shares@ €9.3785100.0% of flow
Common Stock
SEC:0000899243-21-027794·
€41,6504,441 shares@ €9.378537.0% of flow
Common Stock
SEC:0000899243-21-027794:0·
04,610 shares0
Common Stock
SEC:0001567619-21-012873·
04,610 shares0
Common Stock
SEC:0001567619-21-012873:0·
8 of 8 declarations
About Peters Richard
Richard Peters is President and CEO at Aprea Therapeutics, Inc. and Yumanity Therapeutics, Inc. He is responsible for the overall direction and strategy of the companies. His role is essential in guiding initiatives and ensuring growth.
